Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project

[1]  K. Ziada,et al.  Incidence and Outcomes of Non-ST Elevation Myocardial Infarction in Patients Hospitalized with Decompensated Diabetes. , 2018, The American journal of cardiology.

[2]  H. Gilutz,et al.  Short and long-term prognosis following acute myocardial infarction according to the country of origin. Soroka acute myocardial infarction II (SAMI II) project. , 2018, International journal of cardiology.

[3]  Chen-Ying Hung,et al.  Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study , 2018, Cardiovascular Diabetology.

[4]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[5]  Hung-Yu Chang,et al.  Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke , 2018, Cardiovascular Diabetology.

[6]  D. Grobbee,et al.  Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes , 2018, Diabetes & vascular disease research.

[7]  S. Verma,et al.  Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes. , 2017, Journal of the American College of Cardiology.

[8]  L. Heilbronn,et al.  Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data , 2017, Cardiovascular Diabetology.

[9]  E. Tai,et al.  Longitudinal trends in HbA1c and associations with comorbidity and all-cause mortality in Asian patients with type 2 diabetes: A cohort study. , 2017, Diabetes research and clinical practice.

[10]  R. Jiménez-García,et al.  Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014) , 2017, Cardiovascular Diabetology.

[11]  F. Valent,et al.  Does diabetes mellitus comorbidity affect in-hospital mortality and length of stay? Analysis of administrative data in an Italian Academic Hospital , 2017, Acta Diabetologica.

[12]  A. Majeed,et al.  Gender differences in hospital admissions for major cardiovascular events and procedures in people with and without diabetes in England: a nationwide study 2004–2014 , 2017, Cardiovascular Diabetology.

[13]  Yuehua Wu,et al.  Hemoglobin A1c is associated with severity of coronary artery stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplasty , 2017, Cardiovascular Diabetology.

[14]  Chun-Peng Liu,et al.  The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction , 2017, Cardiovascular Diabetology.

[15]  Eliot A Brinton,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[16]  Xuefeng Yu,et al.  Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes , 2017, Cardiovascular Diabetology.

[17]  Xiao-fan Guo,et al.  Gender-specific association of decreased estimated glomerular filtration rate and left vertical geometry in the general population from rural Northeast China , 2017, BMC Cardiovascular Disorders.

[18]  J. Park,et al.  Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006–2013) , 2017, Cardiovascular Diabetology.

[19]  J. Shaw,et al.  Stress hyperglycaemia in critically ill patients and the subsequent risk of diabetes: a systematic review and meta-analysis , 2016, Critical Care.

[20]  Sidney C. Smith,et al.  Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. , 2016, American heart journal.

[21]  G. Lemesle,et al.  A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction. , 2016, International journal of cardiology.

[22]  A. Tahrani,et al.  Future glucose-lowering drugs for type 2 diabetes. , 2016, The lancet. Diabetes & endocrinology.

[23]  M. Pfeffer,et al.  Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome. , 2016, The New England journal of medicine.

[24]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[25]  Baris Gencer,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .

[26]  B. Zinman,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.

[27]  中华医学会心血管病学分会流行病学组,et al.  糖代谢异常与动脉粥样硬化性心血管疾病临床诊断和治疗指南 , 2015 .

[28]  Harlan M Krumholz,et al.  ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data , 2015, The Lancet.

[29]  A. Jaffe,et al.  A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2015 .

[30]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[31]  Guang Ning,et al.  Diabetes in China: a societal solution for a personal challenge. , 2014, The lancet. Diabetes & endocrinology.

[32]  Jun Zhu,et al.  Newly diagnosed and previously known diabetes mellitus and short-term outcomes in patients with acute myocardial infarction , 2013, Coronary artery disease.

[33]  Jane A. Linderbaum,et al.  2013 ACCF/AHA Guideline for the Management of ST‐Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[34]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[35]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[36]  Jun Zhu,et al.  [Clinical characteristics, treatments and outcome of diabetic patients with non-ST elevation acute coronary syndromes in China]. , 2011, Zhonghua xin xue guan bing za zhi.

[37]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[38]  Qun Liu,et al.  [Study on the prevalence of diabetes mellitus among acute coronary syndrome inpatients in a multiprovincial study in China]. , 2008, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[39]  P. Raskin,et al.  Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. , 2008, Circulation.

[40]  Christopher P Cannon,et al.  Diabetes and mortality following acute coronary syndromes. , 2007, JAMA.

[41]  D. Hu,et al.  The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. , 2006, European heart journal.

[42]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[43]  J. Gore,et al.  Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. , 2004, Archives of internal medicine.

[44]  Á. Avezum,et al.  Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.

[45]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.